Science & Enterprise subscription

Follow us on Twitter

  • An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later ho… https://t.co/TupWwuG3ok
    about 18 hours ago
  • New post on Science and Enterprise: Home-Based Cancer Care Boosts Outcomes, Cuts Costs https://t.co/9zcrG432As #Science #Business
    about 18 hours ago
  • Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19...… https://t.co/nUXjHixhfe
    about 19 hours ago
  • A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received a… https://t.co/MOueVM6Nqj
    about 24 hours ago
  • New post on Science and Enterprise: NIH Funds Light-Aided Gene Therapy for Eye Disease https://t.co/CnDzdinH43 #Science #Business
    about 24 hours ago

Please share Science & Enterprise

Drug Maker Licenses Low-Dose Vaccine Patch

Nanopatch system

The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch

Health Research Commercialization Company Launched

Microscope

University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market. . . . → Read More: Health Research Commercialization Company Launched

Antibody Drug Biotech Raises $105M in Venture Funds

Human B-cell

A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds

Merck Inks Three Covid-19 Vaccine, Therapy Deals

SARS-Cov-2 virus

Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals

Psychiatric Drug Maker Raises $80M in Venture Funds

Psilocybe aztecorum

A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing. . . . → Read More: Psychiatric Drug Maker Raises $80M in Venture Funds

Infographic – Biotech Remains Hottest Venture Sector

A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars. . . . → Read More: Infographic – Biotech Remains Hottest Venture Sector

Venture Deals Decline in Q1, Biotech Sizzles Again

The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors. . . . → Read More: Venture Deals Decline in Q1, Biotech Sizzles Again

Infographic – Biotech Index Dives, Rebounds

NBI Jan-Apr 2020

We check in from time to time on the Nasdaq Biotechnology Index as an indicator of the overall health of research-based businesses in the U.S. . . . → Read More: Infographic – Biotech Index Dives, Rebounds

Signs You Are Ready to Invest in Real Estate

Here you can find out if you are emotionally and financially ready. . . . → Read More: Signs You Are Ready to Invest in Real Estate

Venture-Backed Start-Ups to Get Small Biz Loans

Investing monitor

An industry group says rules for loans to small companies hard-hit by Covid-19 are changed to allow these loans for more start-ups funded by venture capital. . . . → Read More: Venture-Backed Start-Ups to Get Small Biz Loans